What’s on tap at HLTH, the health care industry jamboree that kicks off this weekend
STAT’s Mohana Ravindranath and Annalisa Merelli will be at HLTH in Las Vegas and will…
Author: STAT
.jpg)
STAT+: FDA advisory panel signals lack of confidence in data on Amgen’s cancer drug
The clearance of a first-of-its-kind cancer treatment made by Amgen is on shakier ground following…
FDA expert panel endorses idea of removing a component from flu vaccine
The Food and Drug Administration’s expert vaccine advisory panel on Thursday unanimously endorsed the idea…
Listen: Is the Nobel committee evolving? Plus, preventing public health’s wiliest virus
Will we ever get an HIV vaccine? And is the oft-criticized institution that awards the…
STAT+: Neurocrine reports second late-stage trial success for congenital adrenal hyperplasia drug
SAN DIEGO — Neurocrine Biosciences, a biotech focused on treating rare neurological and endocrine diseases,…
STAT+: Telehealth claims data suggest service duplication, Roche app to evaluate MS symptom
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how tech…
The future of health care in the House
You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter in your…
Moderna’s plan to make a single vaccine for Covid, influenza, and RSV is on track
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: Novo faces patent challenge on Wegovy and Ozempic; Senate panel moves to address drug shortages
Rise and shine, another busy day is on the way. We can tell because the…
Cancer drug shortage eases slightly, but it’s still ‘living from paycheck to paycheck’
The shortage of cancer drugs is not going away, but it may be easing slightly,…
STAT+: Kyowa Kirin to acquire Orchard Therapeutics, maker of gene therapy Libmeldy
LONDON — The Japanese firm Kyowa Kirin is acquiring gene therapy maker Orchard Therapeutics in…
Scientists want to put carbon footprints on drugs. But it’s hard to get accurate numbers
Anyone picking up a prescription from their pharmacy is used to the reams of paper…
Opinion: Phenylephrine is no better than a placebo. What if that’s still better than nothing?
As the temperatures cool, the season of colds, flu, and now Covid-19 is heating up….
STAT+: 3 questions for the future of Biden’s cancer moonshot
WASHINGTON — The latest phase of President Biden’s Cancer Moonshot initiative leaves open a few…
Opinion: How health care organizations can set up chief medical officers up for success
It should be obvious that medical school and clinical experience, in themselves, can’t fully prepare…
STAT+: Failed biotech gives a rare peek inside the tough breaks — and tough choices — that led to its demise
SAN DIEGO — It was spring 2020, and Histogen, a small biotech with big ambitions…
Say goodbye to the Covid-19 vaccination card. The CDC has stopped printing them
It’s the end of an era for a once-critical pandemic document: The ubiquitous white Covid-19…
STAT+: Was Amgen less than forthcoming about FDA’s concerns on its cancer drug?
Amid the stunning rebuke Amgen suffered at the hands of the U.S. Food and Drug…
STAT+: Federal bill would keep addiction medication from triggering a child abuse investigation
When Keri McCallum‘s doctor prescribed her Suboxone, she was told it was the “safest thing…
Esketamine tops quetiapine for treatment-resistant depression in head-to-head trial
Nasal esketamine spray is more effective than an extended-release antipsychotic, when both are taken in…
STAT+: Key Senate panel eyes action on drug shortages
WASHINGTON — One of the top health care committees in the Senate is assembling ideas…
STAT+: Consumer watchdog sues diagnostic firm EpicGenetics, alleging misleading claims about fibromyalgia test
The consumer watchdog group the Center for Science in the Public Interest filed a lawsuit…
STAT+: To prevent amputation in patients with severe vascular disease, a device turns veins into arteries
An innocuous slip while cutting her toenails created a wound on Cynthia Elford’s right foot…
STAT+: FDA cites Fresenius Kabi for contamination problems that CDC linked to deadly sepsis cases
Several cases of sepsis — three of which ended in patients deaths — were traced…
FDA calls for treatments for meth and cocaine addiction
No medication is approved to treat addiction to either methamphetamine or cocaine. But the Food…
The major biotech news updates you need to read today
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: FDA finds ‘potential systemic bias’ in Amgen cancer drug trial; drugmakers organize to push back on antitrust reviews
Hello, everyone, and how are you this fine, sunny morning? The middle of the week…
2023 Nobel Prize in chemistry: Trio win for quantum dots discoveries that revolutionized nanotechnology
The 2023 Nobel Prize in chemistry was awarded Wednesday to three scientists for the discovery…
Opinion: The case against age limits for politicians
A recent poll from YouGov/CBS News showed that 77% of respondents said that there should…
STAT+: Gene therapy makers wonder if they can make a profit in Europe. Patients fear being left behind — again
LONDON — It was when she was 12 that doctors first raised the prospect of…
Opinion: Listen: How two abortion providers grapple with their post-Roe reality
Physicians Alison Block and Nikki Zite knew what they were getting into when they became…
STAT+: Colombia set to issue a compulsory license for an HIV medicine sold by GSK’s ViiV
In the latest battle over access to medicines, Colombian authorities have decided to issue a…
FDA authorizes Novavax’s updated Covid-19 vaccine
The Food and Drug Administration on Tuesday authorized Novavax’s updated Covid-19 vaccine, giving Americans seeking…
STAT+: FDA finds ‘potential systemic bias’ in Amgen’s KRAS drug trial ahead of advisory meeting
A follow-up study of a first-of-its-kind cancer treatment may reflect systemic biases, the Food and…
When is a Wall Street disappointment ‘good enough’ for the FDA?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: Drugmakers agree to negotiate Medicare prices under protest; AstraZeneca settles lawsuits over heartburn drugs
Top of the morning to you, and a fine one it is. Cool breezes and…
.jpg)
STAT+: Lilly bolts another one on, acquiring Point Therapeutics for $1.4 billion
A couple billion here, a couple billion there, and pretty soon Eli Lilly hopes it…
2023 Nobel Prize winner: Physics award goes to trio for electron breakthroughs
LONDON — Three scientists whose work on electrons widened the world’s understanding of the particles’…
Opinion: How headlines about the RSV antibody injection could cloud parents’ decision-making
As theorists from Samuel Coleridge to Kenneth Burke have noted, language often does our thinking…
As conservative views collide with science, doctors find themselves navigating political landmines
WASHINGTON — It started with a tweet: A year-old, 43-second clip of Kevin Wang talking…
STAT+: Nobel Prize, in a rarity, celebrates a fruitful and durable partnership
The most noteworthy aspect of awarding the Nobel Prize in medicine or physiology to two…
STAT+: Congress extends some pandemic preparedness programs, but not all
WASHINGTON — Congress temporarily extended a few pandemic-preparedness programs when it forestalled a government shutdown…
WHO recommends second malaria vaccine, hoping to address supply issues
Just two years after the World Health Organization’s historic recommendation of the first malaria vaccine,…
STAT+: Verily lands $38 million deal with CDC for wastewater surveillance
Alphabet’s life sciences company Verily has scored its first Centers for Disease Control contract, a…
The stability of $0 premiums in Medicare Advantage
You’re reading the web edition of Health Care Inc., STAT’s weekly newsletter following the flow…
STAT+: Court strikes down Trump-era rule that allowed health insurers to broadly use copay accumulators
A U.S. judge has struck down a Trump administration rule that allowed health insurers not…
STAT+: Former FDA official lays out how to keep patients safe from risky medical devices
Madris Kinard’s unlikely journey to becoming a champion for patient safety started in a fire…
Here’s what’s moving the needle in biotech stock, in the final quarter of a dismal year
Want to stay on top of the science and politics driving biotech today? Sign up…
STAT+: Pharmalittle: Court allows Medicare drug price negotiation to proceed; J&J will not enforce patents on key TB drug
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
CDC proposes new antibiotics policy aimed at reducing STIs
The Centers for Disease Control and Prevention is proposing a new policy aimed at dramatically…